SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.895-4.5%2:53 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: HardToFind who wrote (3342)12/11/2014 11:18:06 PM
From: Kirk ©  Read Replies (1) of 12871
 
Great answers, thanks.
On the other hand, if you are cash flow positive or well funded for making it to profitability, a low share price doesn't matter as much.

That is what I was thinking. IF they are successful in the next year, people might start lining up with buckets of cash to partner...

Ever the skeptic, I wonder why Pfizer or some other smart people haven't stepped in to buy shares....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News